Clinical trialNCT01151215TerminatedPhase 2Interventional

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

SponsorAstraZenecaEnrollment482Breast CancerBreast NeoplasmsNeoplasms

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dr Serban Ghiorghiu, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗
Stephen Johnston, MA, PhD, FRCP
The Royal Marsden Hospital, London
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil

Research Site
Belo Horizonte, Brazil
Research Site
Goiânia, Brazil
Research Site
Ijuí, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Rio de Janeiro, Brazil
Research Site
São Paulo, Brazil

Canada

Research Site
Vancouver, British Columbia, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Montreal, Quebec, Canada

Czechia

Research Site
Brno, Czechia
Research Site
Olomouc, Czechia
Research Site
Prague, Czechia

Finland

Research Site
Helsinki, Finland
Research Site
Tampere, Finland
Research Site
Turku, Finland

India

Research Site
Bangalore, India
Research Site
Hyderabad, India
Research Site
Mumbai, India
Research Site
Pune, India
Research Site
Trivandrum, India
Research Site
Vellore, India

Japan

Research Site
Niigata, Japan
Research Site
Osaka, Japan
Research Site
Ota-shi, Japan
Research Site
Sapporo, Japan

Mexico

Research Site
Durango, Mexico
Research Site
Juchitán, Mexico
Research Site
Monterrey, Mexico
Research Site
Mérida, Mexico

Peru

Research Site
Callao, Peru
Research Site
Lima, Peru
Research Site
Piura, Peru

Philippines

Research Site
Iloilo City, Philippines
Research Site
Lipa City, Philippines
Research Site
Pasay, Philippines
Research Site
Quezon City, Philippines

Poland

Research Site
Bialystok, Poland
Research Site
Elblag, Poland
Research Site
Krakow, Poland
Research Site
Warsaw, Poland

20 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2010
Primary completion: 31 Jan 2013
Completion: 31 Jan 2013
Last update posted: 25 Jul 2014
Registered enrollment: 482
Registry id: NCT01151215

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.